<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang Y</submitter><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>e202300081</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11081099</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(10-11)</volume><pubmed_abstract>Truncated mucin-type O-glycans, such as Tn-associated antigens, are aberrantly expressed biomarkers of cancer, but remain challenging to target. Reactive antibodies to these antigens either lack high-affinity or are prone to antigen escape. Here, we have developed a robust chemoenzymatic strategy for the global labeling of Tn-associated antigens, i.e. Tn (GalNAcα-O-Ser/Thr), Thomsen-Friedenreich (Galβ1-3GalNAcα-O-Ser/Thr, TF) and STF (Neu5Acα2-3Galβ1-3GalNAcα-O-Ser/Thr, STF) antigens, in human whole blood with high efficiency and selectivity. This method relies on the use of the O-glycan sialyltransferase ST6GalNAc1 to transfer a sialic acid-functionalized adaptor to the GalNAc residue of these antigens. By tagging, the adaptor functionalized antigens can be easily targeted by customized s</pubmed_abstract><journal>Israel journal of chemistry</journal><pubmed_title>Chemoenzymatic Tagging of Tn/TF/STF Antigens in Living Systems.</pubmed_title><pmcid>PMC11081099</pmcid><funding_grant_id>P41 GM103390</funding_grant_id><funding_grant_id>R35 GM139643</funding_grant_id><funding_grant_id>P01GM107012</funding_grant_id><funding_grant_id>R01GM117145</funding_grant_id><funding_grant_id>R01 GM130915</funding_grant_id><funding_grant_id>U01 GM120408</funding_grant_id><funding_grant_id>U01GM120408</funding_grant_id><funding_grant_id>R01GM130915</funding_grant_id><funding_grant_id>P01 GM107012</funding_grant_id><funding_grant_id>P41 GM103390</funding_grant_id><funding_grant_id>R01 GM117145</funding_grant_id><funding_grant_id>R35GM139643</funding_grant_id><pubmed_authors>Yang JY</pubmed_authors><pubmed_authors>Gao B</pubmed_authors><pubmed_authors>Sharpless KB</pubmed_authors><pubmed_authors>Wu M</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Young TS</pubmed_authors><pubmed_authors>Chapla DG</pubmed_authors><pubmed_authors>Wu P</pubmed_authors><pubmed_authors>Cappiello JR</pubmed_authors><pubmed_authors>Moremen KW</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Yu C</pubmed_authors><pubmed_authors>Li JP</pubmed_authors><pubmed_authors>Hong S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chemoenzymatic Tagging of Tn/TF/STF Antigens in Living Systems.</name><description>Truncated mucin-type O-glycans, such as Tn-associated antigens, are aberrantly expressed biomarkers of cancer, but remain challenging to target. Reactive antibodies to these antigens either lack high-affinity or are prone to antigen escape. Here, we have developed a robust chemoenzymatic strategy for the global labeling of Tn-associated antigens, i.e. Tn (GalNAcα-O-Ser/Thr), Thomsen-Friedenreich (Galβ1-3GalNAcα-O-Ser/Thr, TF) and STF (Neu5Acα2-3Galβ1-3GalNAcα-O-Ser/Thr, STF) antigens, in human whole blood with high efficiency and selectivity. This method relies on the use of the O-glycan sialyltransferase ST6GalNAc1 to transfer a sialic acid-functionalized adaptor to the GalNAc residue of these antigens. By tagging, the adaptor functionalized antigens can be easily targeted by customized s</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T01:03:21.056Z</modification><creation>2025-04-04T01:03:21.056Z</creation></dates><accession>S-EPMC11081099</accession><cross_references><pubmed>38737670</pubmed><doi>10.1002/ijch.202300081</doi></cross_references></HashMap>